Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.62 is 11% below its 5-year average of 1.82, around the middle of its 5-year range (0.61–3.14).
As of the fiscal period ended Tuesday, June 30, 2026. 4.56% above its 12-month average of 1.55.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.62.
QUICK RATIO (ACID-TEST)
1.62
QUICK RATIO (ACID-TEST) AVG TTM
1.55
QUICK RATIO (ACID-TEST) AVG 3Y
1.30
QUICK RATIO (ACID-TEST) AVG 5Y
1.82
QUICK RATIO (ACID-TEST) AVG 10Y
4.98
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+4.56%
CURRENT VS 3Y AVG
+24.75%
CURRENT VS 5Y AVG
-10.89%
CURRENT VS 10Y AVG
-67.42%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-51.61%
vs the sector median at left
Market Cap
$120.41M
Quick Ratio (Acid-Test)
14.06
TTM Avg
14.20
3Y Avg
21.81
5Y Avg
28.51
Market Cap
$120.58M
Quick Ratio (Acid-Test)
10.21
TTM Avg
11.59
3Y Avg
10.00
5Y Avg
8.96
Market Cap
$118.83M
Quick Ratio (Acid-Test)
13.31
TTM Avg
17.30
3Y Avg
10.78
5Y Avg
9.73
Market Cap
$118.59M
Quick Ratio (Acid-Test)
4.52
TTM Avg
5.53
3Y Avg
5.99
5Y Avg
10.25
Market Cap
$117.76M
Quick Ratio (Acid-Test)
9.23
TTM Avg
4.04
3Y Avg
4.74
5Y Avg
7.63
Market Cap
$122.43M
Quick Ratio (Acid-Test)
0.65
TTM Avg
1.74
3Y Avg
2.55
5Y Avg
2.19
Market Cap
$122.66M
Quick Ratio (Acid-Test)
6.61
TTM Avg
6.63
3Y Avg
5.56
5Y Avg
6.65
Market Cap
$116.76M
Quick Ratio (Acid-Test)
11.47
TTM Avg
9.04
3Y Avg
10.96
5Y Avg
10.73
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cibus, Inc. (CBUS) | $119.84M | 1.62 | 1.55 | 1.30 | 1.82 |
| Seer, Inc. (SEER)vs › | $120.41M | 14.06 | 14.20 | 21.81 | 28.51 |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | 10.21 | 11.59 | 10.00 | 8.96 |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | 13.31 | 17.30 | 10.78 | 9.73 |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $118.59M | 4.52 | 5.53 | 5.99 | 10.25 |
| Spruce Biosciences, Inc. (SPRB)vs › | $117.76M | 9.23 | 4.04 | 4.74 | 7.63 |
| BGM Group Ltd. (BGM)vs › | $122.43M | 0.65 | 1.74 | 2.55 | 2.19 |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | 6.61 | 6.63 | 5.56 | 6.65 |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | 11.47 | 9.04 | 10.96 | 10.73 |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | 3.36 | 3.23 | 4.24 | 6.08 |
Quick Ratio
1.62
Excludes inventory
Current Ratio
1.62
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.62 |
| 2026-03-31 | 2.37 |
| 2025-12-31 | 0.72 |
| 2025-09-30 | 1.28 |
| 2025-06-30 | 1.78 |
| 2025-03-31 | 1.23 |
| 2024-12-31 | 0.85 |
| 2024-09-30 | 1.44 |
| 2024-06-30 | 1.14 |
| 2024-03-31 | 1.23 |
| 2023-12-31 | 1.65 |
| 2023-09-30 | 1.37 |
| 2023-06-30 | 2.44 |
| 2023-03-31 | 0.61 |
| 2022-12-31 | 2.49 |
| 2022-09-30 | 1.88 |
| 2022-06-30 | 2.86 |
| 2022-03-31 | 1.99 |
| 2021-12-31 | 3.13 |
| 2021-09-30 | 3.03 |
| 2021-06-30 | 3.14 |
| 2021-03-31 | 3.89 |
| 2020-12-31 | 5.50 |
| 2020-09-30 | 4.08 |
| 2020-06-30 | 8.29 |
| 2020-03-31 | 8.80 |
| 2019-12-31 | 8.47 |
| 2019-09-30 | 11.97 |
| 2019-06-30 | 15.94 |
| 2019-03-31 | 18.63 |
| 2018-12-31 | 13.64 |
| 2018-09-30 | 14.98 |
| 2018-06-30 | 21.26 |
| 2018-03-31 | 17.78 |
| 2017-12-31 | 13.51 |
| 2017-09-30 | 12.40 |
| 2017-06-30 | 0.36 |
| 2017-03-31 | 0.91 |
| 2016-12-31 | 1.91 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
